Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Laboratories OGM-Dx HemeOne Test

Bionano Laboratories, a subsidiary of Bionano Genomics, has launched OGM-Dx HemeOne, a laboratory-developed test based on optical genome mapping (OGM). The assay analyzes blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. According to Bionano, the reports from OGM-Dx HemeOne will include a targeted analysis of guidelines-based, disease-specific SVs, and a whole-genome analysis for the detection of recurrent and novel biomarkers associated with various hematological malignancy indications.